U.S. drug regulators need further clinical data, possibly including new clinical studies, before approving a new diabetes drug from AstraZeneca and Bristol-Myers Squibb. The two companies said on Thursday they had received a so-called “complete response letter” from the Food and Drug Administration (FDA) for dapagliflozin as a treatment for type 2 diabetes in adults. Continue reading
Follow Me
-
Some Recent Posts
-
Dear pharma: I’m sorry but I don’t trust you anymore
8 days ago -
How to save $550 billion in healthcare costs
9 days ago -
The truth about prescription drugs
10 days ago -
The weekly healthcare news roundup
13 days ago -
Healthcare costs in the US are the highest in the world
14 days ago -
Time for the drug industry to get serious about digital marketing
14 days ago -
Dear drug companies: Please find a way to stop cancer !
15 days ago -
Online video viewers abandoning clips after just 10 secs
15 days ago -
New drug product launches in the age of the blockbuster
16 days ago -
The costs of obesity cost us all
17 days ago -
A wrap of this weeks healthcare news
20 days ago -
Can patients trust new drugs ?
21 days ago -
40 percent of scientific papers published in the world’s top medical journals misrepresented the actual findings of the research
22 days ago -
High Cost of Medical Care Destroying the Health of Americans
23 days ago -
Does being an empowered patient mean being a bad patient ?
24 days ago
-
Dear pharma: I’m sorry but I don’t trust you anymore
Google+
Categories
- Bad practices (34)
- Book Review (1)
- Business of the drug industry (71)
- Contrarians POV (5)
- Cost of healthcare in the U.S. (63)
- FDA (10)
- FDA and drug studies (1)
- Focus on patients (70)
- Health information (43)
- Health information online (28)
- in the news (44)
- Internet (18)
- Marketing to health care professionals (11)
- Medical Device business (2)
- Medical Devices (9)
- Mobile Healthcare Marketing (5)
- Mobile healthcare marketing & trends (4)
- Patient Wellness (9)
- Prescription drug DTC marketing (30)
- Social media and healthcare (50)
- Technology and healthcare (2)
- Trends in consumer healthcare marketing (6)
- Unbranded DTC marketing (1)
- Weekly news (27)
- Weekly news mash-up (34)
- Working in the industry (32)
Blogroll
- Dr Mintz's BLOG Board certified in internal medicine and has been practicing for over a decade. He is also an Associate Professor of Medicine at an academic medical center on the East Coast.
- Internet Drug News Pharmaceutical News & Information; Updated Daily since 1998
- Manhattan Research Manhattan Research is a global pharmaceutical and healthcare market research and advisory firm focused on the digital trends shaping the future of consumer and physician marketing
- My Online CV I enjoy consulting but I am looking to join an organization that is is need of a marketing Linchpin. I can make it happen and bring a new view of marketing today to your company.
- New Media & Marketing A passionate marketers view of the changing world of marketing and the use of digital marketing to reach empowered consumers
- Online Strategic Solutions My consulting company. From strategy development to taking the lead on market research I provide real results that matter not a lot of consultant garbage.
- Pharma Marketing Blog John Mack’s pharma marketing blog is a good one. He takes a common sense approach to DTC and pharma marketing in general.
- Pharmalot Ed Silverman’s BLOG has been quoted by a lot of people in the media and is a must read if you follow healthcare marketing
- PM 360 Magazine PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries.


















